The healthcare costs of treating human papillomavirus-related cancers in Norway

BMC Cancer

Table 4 Cost per patient (€) the first, second and third year of diagnosis according to cancer type, 2012–2014, €1.00 = NOK 8.357^a

	Cost (€) per patient
Cancer diagnosis by year of treatment^b	No. of patients	Mean	Std.	Median
Cervical cancer
1st	954	32,220	27,989	26,324
Proportion of total cost first 3 years (%)		(90.71)
2nd	290	8989	20,572	892
3rd	99	5436	13,660	375
Total cost first 3 years	954	35,518	33,556	27,358
Vaginal cancer
1st	28	30,210	15,234	30,971
Proportion of total cost first 3 years (%)		(97.68)
2nd	7	2712	5747	500
3rd	2	563	265	563
Total cost first 3 years	28	30,928	15,352	33,782
Vulvar cancer
1st	224	23,798	22,066	20,024
Proportion of total cost first 3 years (%)		(90.61)
2nd	53	8550	18,035	731
3rd	13	7655	12,501	487
Total cost first 3 years	224	26,265	26,342	22,523
Penile cancer
1st	141	16,085	21,828	8222
Proportion of total cost first 3 years (%)		(87.66)
2nd	38	8311	21,397	713
3rd	9	396	119	356
Total cost first 3 years	141	18,350	26,245	8466
Anal cancer
1st	330	26,876	25,934	21,692
Proportion of total cost first 3 years (%)		(88.83)
2nd	111	8221	18,460	1426
3rd	43	4720	11,079	951
Total cost first 3 years	330	30,256	31,223	23,415
Oropharyngeal cancer
1st	564	48,055	37,376	41,362
Proportion of total cost first 3 years (%)		(96.55)
2nd	215	3965	11,619	536
3rd	77	1515	8244	212
Total cost first 3 years	564	49,774	39,737	41,651

ISSN: 1471-2407